Navigation Links
Cell Therapeutics Amends 'Modified Dutch Auction' Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes
Date:5/18/2009

SEATTLE, May 18 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (the "Company" or "CTI") (Nasdaq and MTA: CTIC) today announced that it has amended its "Modified Dutch Auction" tender offer (the "Exchange Offer") to increase the total consideration of its offer to exchange shares of its common stock, no par value (the "Common Stock"), and cash for an aggregate of up to $89.2 million principal amount of the following outstanding series of its convertible notes (the "Notes"):

  • 4% Convertible Senior Subordinated Notes due 2010
  • 5.75% Convertible Senior Notes due 2011
  • 6.75% Convertible Senior Notes due 2010
  • 7.5% Convertible Senior Notes due 2011
  • 9% Convertible Senior Notes due 2012

Under the Exchange Offer, as amended, CTI will now offer to exchange shares of Common Stock and cash with a value not greater than $600 nor less than $550 (the "Exchange Consideration") for each $1,000 principal amount of Notes validly tendered and not withdrawn, with such value determined by a "Modified Dutch Auction" procedure. Originally, the minimum value had been $250 per $1,000 principal amount and the maximum value had been $300 per $1,000 principal amount. The cash portion of the Exchange Consideration will continue to be $200. Accrued and unpaid interest to, but excluding, the settlement date will continue to be exchanged for shares of Common Stock.

As a result of the increase in the portion of the Exchange Consideration consisting of shares of Common Stock, the Company has increased the maximum number of shares of Common Stock to be issued upon exchange of the Notes and to pay accrued and unpaid interest to 30.63 million shares of Common Stock.

A "Modified Dutch Auction" tender offer allows holders of the Notes to indicate the principal amount of Notes that such holders desire to tender
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Nile Therapeutics CD-NP Clinical Program for Acute Heart Failure Released From Clinical Hold by FDA
2. Fate Therapeutics Granted Exclusive License for Stem Cell Modulators by Childrens Hospital Boston and Massachusetts General Hospital
3. Cell Therapeutics Closes Italian Facility, Reduces Headcount and Expects to Cut $14 Million in Operating Expenses
4. Cell Therapeutics, Inc. (CTI) to Present at 2009 BIO International Convention
5. Orexigen(R) Therapeutics to Present at Upcoming Meetings
6. Prospect Therapeutics, Inc. Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors
7. Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a Modified Dutch Auction Tender Offer
8. PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration
9. Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy
10. Amicus Therapeutics to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 13, 2009
11. Orexigen(R) Therapeutics to Speak at Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Dr. Sparano is Professor of Medicine and ... Albert Einstein College of Medicine and Associate Chairman of ... He is also Associate Director for Clinical Research ... Breast Cancer Working Group, a multidisciplinary group of physicians ... also serves as Vice Chair of the National Cancer ...
(Date:5/17/2013)... in German . ... naked eye, you can see which branch a bird is ... branches through the telephoto lens for high-magnification images requires considerable ... looking to study proteins, the active biomolecules of cells. , ... Molecular Systems Biology, and her colleagues have now come up ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 •    First of ... Certified for sustainability ,     New facility will help ... , Syngenta unveiled its new crop ... the company’s RTP Innovation Center. The first of its ... to simulate any agricultural climate and precisely measure plant ...
(Date:5/17/2013)... , May 17, 2013  Yongye International, Inc. ... a leading developer, manufacturer, and distributor of crop nutrient ... , today announced that, on May 16, 2013, ... of directors (the "Board of Directors") was provided a ... Hong Kong ) Limited ("Abax") to Full ...
Breaking Biology Technology:Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4
... 28 Millennium,Biotechnologies Group, Inc. (OTC Bulletin Board: ... Company as Executive Vice President of,International Sales and ... Custodio,has over 30 years of experience in the ... products into,international markets., As Executive Vice President ...
... together on innovative bone protein technology ... and CEO of,Therapure BioPharma Inc. and Dr. Cameron ... announced a development partnership utilizing,an innovative approach to ... stimulating bone regeneration. Such growth factors are critical,tools ...
... - PlasmaBlade Needle and PlasmaBlade EXT Extend PlasmaBlade Family of, ... Than 150 Surgical ... FDA Clearance in July -, PALO ALTO, Calif., Oct. ... developed a new tissue dissection system,based on a proprietary technology, ...
Cached Biology Technology:Benjamin Custodio Joins Millennium Biotechnologies to Expand International Sales 2Benjamin Custodio Joins Millennium Biotechnologies to Expand International Sales 3Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc. 2PEAK Surgical Introduces PlasmaBlade(TM) Product Line Extensions for Use in General Surgery 2PEAK Surgical Introduces PlasmaBlade(TM) Product Line Extensions for Use in General Surgery 3
(Date:5/16/2013)... The use of genome-wide analysis (GWA), where the entirety ... the genomic mutations or variants which can cause health ... However, it can also pose major ethical problems ... Society of Human Genetics (ESHG) published on line today ... Human Genetics ., Many services based on whole genome ...
(Date:5/16/2013)... conservationist working in Cameroon and the manager of San ... awarded the prestigious Whitley award. The Whitley award ... Green Oscars" because it celebrates the extraordinary achievements of ... countries. Abwe was selected for the award due ... Ebo Forest and its wildlife inhabitants., HRH The Princess ...
(Date:5/16/2013)... May 16, 2013 Reportlinker.com announces ... available in its catalogue: ... 2018 http://www.reportlinker.com/p01181929/Global-Biometric-Systems-Market-Forecast--Opportunities-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Security_Systems ... security practises such as photographs, passwords and ... biometric technologies in last few years. Security ...
Breaking Biology News(10 mins):European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3Global Biometric Systems Market Forecast & Opportunities, 2018 2Global Biometric Systems Market Forecast & Opportunities, 2018 3Global Biometric Systems Market Forecast & Opportunities, 2018 4Global Biometric Systems Market Forecast & Opportunities, 2018 5Global Biometric Systems Market Forecast & Opportunities, 2018 6Global Biometric Systems Market Forecast & Opportunities, 2018 7
... A massive, growing pool of icy meltwater in the Arctic ... researchers said today. Estimated in 2009 at more ... Africa,s Lake Victoria and growing, the water could flush ... patterns shift, as occurred most recently in the 1960s and ...
... -- Sealants, like weather stripping, are what separates the ... barrier that prevents water from seeping in, for example, ... chemist Christopher White of the National Institute of Standards ... they will fail. Current methods test sealants statically, ...
... release is available in Spanish . ... at the XXVI National Congress on Human Genetics held in ... concretely, it is based on microarray technology (genomic hybridisation genetic ... the common cytogenetic techniques. The new device, known as Amniochip, ...
Cached Biology News:Icy meltwater pooling in Arctic Ocean: A wild card in climate change scenarios 2Icy meltwater pooling in Arctic Ocean: A wild card in climate change scenarios 3Icy meltwater pooling in Arctic Ocean: A wild card in climate change scenarios 4Icy meltwater pooling in Arctic Ocean: A wild card in climate change scenarios 5Icy meltwater pooling in Arctic Ocean: A wild card in climate change scenarios 6Icy meltwater pooling in Arctic Ocean: A wild card in climate change scenarios 7Icy meltwater pooling in Arctic Ocean: A wild card in climate change scenarios 8Inexpensive new instruments test building sealants under real-world conditions 2New technology capable of detection of 150 genetic syndromes from an amniocentesis 2
Experion StdSens chips are the microfluidic chips used to perform standard-sensitivity RNA analysis (nanogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to...
Experion HighSens chips are the microfluidic chips used to perform high-sensitivity RNA analysis (picogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to ru...
...
...
Biology Products: